403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Cardiac Arrhythmia Monitoring Devices Market Size Worth USD 15.01 Bn By 2034
| Report Coverage | Details | |
| Growth Rate (2025 to 2034) | CAGR of 6.67% | |
| Market Size in 2025 | USD 8.40 Billion | |
| Market Size in 2026 | USD 8.96 Billion | |
| Market Size by 2034 | USD 15.01 Billion | |
| Base Year | 2024 | |
| Forecast Period | 2025 to 2034 | |
| Segments Covered | Device, Application, End-use, and Region | |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa | |
| U.S. Market Size (2024) | USD 2.18 Billion | |
| North America Market Share (2024) | 37% | |
| Fastest-Growing Region | Asia-Pacific | |
| Key Growth Drivers | Rising burden of cardiovascular diseases, rapid adoption of wearable and remote cardiac monitoring technologies, expansion of ambulatory ECG testing, increasing focus on early arrhythmia detection. | |
| Key Restraints | Shortage of trained professionals to interpret monitoring data, limited access to advanced devices in lower-income regions. | |
| Major Opportunities | Accelerating use of mobile cardiac telemetry, AI-enabled ECG analytics, and continuous wearable rhythm-monitoring platforms in home-care and telehealth settings. |
Immediate Delivery Available | Buy This Premium Research Report@
Cardiac Arrhythmia Monitoring Devices Market Regional Outlook
What is the U.S. Cardiac Arrhythmia Monitoring Devices Market Size?
The U.S. cardiac arrhythmia monitoring devices market size is calculated at USD 2.33 billion in 2025 and is projected to exceed USD 4.17 billion by 2034, with a solid CAGR of 6.70% between 2025 and 2034.
How did North America Dominate the Cardiac Arrhythmia Monitoring Devices Market?
North America, mainly the U.S., has a high and rising number of atrial fibrillation cases. Lifestyle factors such as sedentary living, obesity, and chronic diseases (diabetes, hypertension) led to this increase. Initiatives to raise the knowledge about arrhythmias and the advantages of monitoring devices among patients and even healthcare providers drive demand.
North America has experienced rapid growth in the prevalence of cardiovascular disease. The rapid industrial focus on advancements of wearable and AI-powered monitoring technologies is bringing significant innovations in the region. Additionally, the sustainable trend of remote patient monitoring and telemedicineThe U.S. dominates the regional Devices market due to its advanced healthcare infrastructure, high prevalence of arrhythmias such as atrial fibrillation, and strong presence of leading medical device manufacturers and health tech innovators. The country benefits from favorable reimbursement policies, robust R&D capabilities, and widespread adoption of remote patient monitoring and telehealth solutions. Additionally, a proactive regulatory environment, including streamlined FDA approval pathways, supports the rapid commercialization of advanced cardiac monitoring technologies, solidifying the U.S. as the regional market leader.
Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.
Try Before You Buy – Get the Sample Report@
Asia Pacific Cardiac Arrhythmia Monitoring Devices Market
A tech-savvy population in countries such as China and India is driving the requirement for connected and even affordable cardiac health devices. Expanding and modernizing healthcare facilities, alongside a rising number of well-trained healthcare professionals, permits the acceptance of the latest cardiac monitoring technologies. There is rising investment in the development of advanced devices, which include premium-priced alternatives and new technologies such as AI-enabled implantable cardiac devices.
Japan dominates the regional market, driven by its highly developed healthcare system, advanced medical technology adoption, and a rapidly aging population, factors that contribute to a higher incidence of cardiac arrhythmias such as atrial fibrillation. The country has a strong domestic manufacturing base, with key players like Nihon Kohden and Fukuda Denshi leading innovations in ECG and remote monitoring technologies.
Why is Europe Showing Significant Growth in the Cardiac Arrhythmia Monitoring Devices Market?
Europe's cardiac arrhythmia monitoring devices market is rising due to a combination of factors, which include the high and even rising prevalence of heart conditions such as atrial fibrillation in the aging population, fast advancements in technology like AI and wearable devices, remarkable investment in R&D, supportive regulatory frameworks, and increased adoption of digital health trends. The advancement of remote and wireless cardiac monitoring devices, like smart ECG monitors and wearable technologiesCountry-Level Funding and Investments in Cardiac Arrhythmia Monitoring Devices:
- United States - InfoBionic (U.S.) secured a Series D funding round to grow its virtual telemetry/remote cardiac monitoring system (MoMe ARC) to expand domestically and internationally, enabling better detection of arrhythmias.
India - Monitra Health (Hyderabad) raised US$1.5 million (Pre-Series A) to expand its“upBeat” remote cardiac monitoring platform for diagnosing arrhythmias (fainting, palpitations, etc.), both domestically and with plans for international certification. Also, Sunfox Technologies raised approximately INR 15 crore (approximately US$1.8 million) to scale its portable ECG device“Spandan”, which aids in real-time arrhythmia detection and cardiac health monitoring.
United Kingdom / Europe - Lifeyear (UK-Estonian startup) secured €2.8 million to accelerate deployment of its remote/digital cardiovascular (heart) care platform across selected NHS hospitals, GP practices, and virtual wards, enabling more remote monitoring of cardiac patients.
Israel - Ultromics, an Oxford-, UK, spinoff with strong Israel-UK connections, raised €48 million (≈ US$55 million) in a Series C round to scale its AI-driven diagnostics for earlier detection of heart failure (which intersects with arrhythmia risk) and to roll out more broadly in its target markets.
Cardiac Arrhythmia Monitoring Devices Market Segmentation Insights
Device Insights
Why did the Holter Monitor Segment Dominate the Cardiac Arrhythmia Monitoring Devices Market?
The Holter monitor segment dominated the market, with a market share of 43% due to its well-known reliability and cost-effectiveness compared to other technologies, making it a preferred alternative for diagnosing intermittent arrhythmias. Holter monitors have a well-known track record and are known for their reliability in capturing heart activity over extended periods. They are user-friendly and do not even need professional medical training for patients to function.
The mobile cardiac telemetry segment is anticipated to grow rapidly in the market during the forecast period, due to rising cardiovascular disease prevalence, technological developments in wearable and smartphone-based apparatus, and the effectiveness of mobile cardiac telemetry in capturing long-term, vital heart rhythm data.
The rising trend of telemedicine and even the shift towards remote patient management create a favorable environment for mobile cardiac telemetry devices, which offer continuous, near-real-time data collection from patients' homes. Thus, it offers comprehensive, long-term heart rhythm information, providing physicians with a better analysis of a patient's cardiac status and even the circumstances surrounding arrhythmias.
Application Insights
Why did the Tachycardia Segment Dominate the Cardiac Arrhythmia Monitoring Devices Market?
The tachycardia segment dominates the market due to the high incidence of atrial fibrillation and a few tachycardic conditions, mainly in aging populations. These arrhythmias can contribute to serious complications like stroke, heart failure, and even sudden cardiac arrest, necessitating early detection along with intervention to prevent these severe results.
The development and acceptance of advanced monitoring devices, which include event recorders, Holter monitors, and even implantable devices, permit the effective recording of electrical heart activity.
End-Use Insights
Why did the Hospitals and Clinics Segment Dominate the Cardiac Arrhythmia Monitoring Devices Market?
The hospitals and clinics segment dominates the market with a share of over 46% in 2024, due to the high volume of cardiac implant procedures, the demand for integrated infrastructure for continuous monitoring, and a large patient inflow demanding timely diagnosis and follow-up care. Hospitals have developed infrastructure and even skilled medical professionals to offer continuous telemetry and comprehensive monitoring, which includes post-procedural observation. Supportive reimbursement policies and even government support for cardiovascular health push hospitals and clinics to procure this advanced monitoring apparatus.
The diagnostic centers segment is expected to grow fastest in the market during the forecast period, due to the rising global prevalence of cardiac arrhythmias, such as atrial fibrillation, which necessitates standard long-term monitoring beyond typical hospital visits. New wearable and implantable monitoring devices offer more precise as well as long-term detection of heart rhythm irregularities, which can be effectively managed in diagnostic centers. The incorporation of AI-based analytics in monitoring devices assists in enhancing the accuracy and even efficiency of diagnostics, thus improving the capabilities of diagnostic centers.
✚ Related Topics You May Find Useful:
➡️ Cardiac Rhythm Management Devices Market➡️ Cardiac Monitoring Market
➡️ Ambulatory Cardiac Monitoring Devices Market
➡️ Wearable Cardiac Devices Market
➡️ Cardiovascular Devices Market
➡️ Cardiac Mapping Market
➡️ Remote Cardiac Monitoring Market
➡️ Digital Patient Monitoring Devices Market
➡️ Electrophysiology Devices Market
➡️ Cardiac Pacemaker Market
➡️ Atrial Fibrillation Devices Market
Top Companies in the Cardiac Arrhythmia Monitoring Devices Market
- Applied Cardiac Systems - Applied Cardiac Systems provides advanced Holter monitoring and cardiac event recording systems designed to detect and analyze arrhythmias in clinical and outpatient settings.
AliveCor - AliveCor offers portable, AI-powered ECG devices like KardiaMobile that enable real-time arrhythmia detection from smartphones, supporting remote cardiac monitoring.
iRhythm Technologies - iRhythm Technologies develops the Zio patch, a wearable ECG monitoring solution that provides continuous long-term monitoring to detect irregular heart rhythms with high diagnostic yield.
Koninklijke Philips N.V. - Philips delivers comprehensive cardiac monitoring solutions, including wearable biosensors and cloud-based analytics, for continuous arrhythmia detection in hospitals and home care environments.
Medtronic plc - Medtronic provides implantable loop recorders and remote cardiac monitoring systems that enable long-term tracking and early detection of arrhythmias in at-risk patients.
Nihon Kohden Corporation - Nihon Kohden offers integrated cardiac monitoring systems, including bedside ECG monitors and telemetry systems, to support accurate arrhythmia diagnosis and real-time monitoring.
Biotronik - Biotronik specializes in implantable cardiac monitors and pacemakers with remote monitoring capabilities to detect and manage complex arrhythmias efficiently.
Biotricity - Biotricity develops connected cardiac monitoring solutions like Bioflux, a real-time, high-precision ECG device that aids in diagnosing and managing cardiac arrhythmias.
GE Healthcare - GE Healthcare provides advanced ECG systems and wearable cardiac monitoring devices equipped with data analytics to support arrhythmia detection across care settings.
St. Jude Medical (Abbott Laboratories) - St. Jude Medical, now part of Abbott, offers a suite of implantable and wearable cardiac monitoring devices that deliver continuous rhythm tracking and data-driven arrhythmia management.
Spacelabs Healthcare (OSI Systems, Inc.) - Spacelabs Healthcare provides telemetry and Holter monitoring systems designed for continuous arrhythmia surveillance and ECG data interpretation in clinical environments.
Welch Allyn (Hillrom Services, Inc.) - Welch Allyn, a Hillrom company, delivers portable ECG devices and connected monitoring solutions that assist in early arrhythmia detection and improved cardiac care workflows.
Recent Developments :
- In September 2025, Biotricity Inc., an innovative medical technology firm specializing in remote cardiac monitoring solutions, and B-Secur, a leader in ECG algorithms, together with biosensing technology, are transforming the consumer wearables market with an improvement to their joint cardiac monitoring platform. This partnership solidifies the company's leadership in digital cardiovascular innovations. Source:
In May 2024, Vivalink, a leading manufacturer of digital healthcare solutions, declared the start of its comprehensive technology solution engineered for Mobile Cardiac Telemetry and Holter monitoring. The solution incorporates remote patient monitoring technologies and developed arrhythmia detection algorithms, streamlining deployment and even improving patient care to meet the rising need for efficient ambulatory ECG monitoring solutions. Source:
Segments Covered in the Report
By Device
- Holter Monitor Event Recorder Mobile Cardiac Telemetry Implantable Cardiac Monitor Electrocardiogram (ECG) Monitor Others
By Application
- Tachycardia
- Atrial Tachycardia Ventricular Tachycardia
By End-Use
- Hospitals and Clinics Diagnostic Centers Ambulatory Surgical Centers Homecare Settings Others
By Region
- North America
- U.S. Canada
- U.K. Germany France
- China India Japan South Korea Malaysia Philippines
- Brazil Rest of Latin America
- GCC North Africa South Africa Rest of the Middle East & Africa
Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as North America, Europe, or Asia Pacific.
Immediate Delivery Available | Buy This Premium Research Report@You can place an order or ask any questions, please feel free to contact at ... | +1 804 441 9344
Stay Ahead with Precedence Research Subscriptions
Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve.
Browse Our Subscription Plans@About Us
Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Web:Our Trusted Data Partners:
Towards Healthcare | Towards Packaging | Towards Automotive | Towards Chem and Materials | Towards FnB | Towards Consumer Goods | Statifacts | Towards EV Solutions | Towards Dental | Nova One Advisor Market Stats Insight | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant Specialty Chemicals AnalyticsGet Recent News:
/newsFor the Latest Update Follow Us:
LinkedIn | Medium | Facebook | Twitter✚ Explore More Market Intelligence from Precedence Research:
➡️ Biopharmaceuticals Growth➡️ Digital Therapeutics
➡️ Life Sciences Growth
➡️ Viral Vector Gene Therapy Manufacturing
➡️ Wellness Transformation
➡️ Generative AI in Healthcare
➡️ Quantum Future
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment